Literature DB >> 9401282

A case of mu-heavy chain disease: combined features of mu-chain disease and macroglobulinemia.

T Iwasaki1, T Hamano, K Kobayashi, E Kakishita.   

Abstract

A case of mu-heavy chain disease (HCD) is described. The patient, a 40-year-old man, presented with an intracranial tumor. The bone marrow of this patient showed infiltration with both plasma cells and lymphocytes. The majority of plasma cells were vacuolated and the result of immunoelectrophoresis of serum protein revealed an arc with anti-IgM antiserum and an additional rapid migrating arc of different mobility with anti-kappa antiserum. The urine contained a kappa-type Bence Jones protein. An enzyme-linked antibody study showed that the majority of plasma cells in bone marrow contained both mu and kappa antigenic determinants in their cytoplasm. On Sephadex G-200 gel filtration, the monoclonal IgM-kappa protein and the mu-chain fragment were detected in the serum, suggesting the combined features of mu-HCD and macroglobulinemia. The molecular weight of the mu-chain fragment was approximately 45,000 daltons. The intracranial tumor completely disappeared after irradiation therapy. However, he died 1 year later after development of a huge abdominal tumor.

Entities:  

Mesh:

Year:  1997        PMID: 9401282     DOI: 10.1016/s0925-5710(97)00039-x

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  4 in total

1.  Multiple extranodal tumors in mu-heavy chain disease.

Authors:  Akinori Maeda; Minako Mori; Satoko Torii; Yuya Nagai; Katsuhiro Togami; Haruyuki Fujita; Masayuki Kurata; Akiko Matsushita; Kenichi Nagai; Yukihiro Imai; Takayuki Takahashi
Journal:  Int J Hematol       Date:  2006-10       Impact factor: 2.490

Review 2.  Successful treatment of mu-heavy chain disease with fludarabine monophosphate: a case report.

Authors:  Machi Yanai; Akinori Maeda; Naoko Watanabe; Naoshi Sugimoto; Akiko Matsushita; Kenichi Nagai; Tatsuo Oida; Takayuki Takahashi
Journal:  Int J Hematol       Date:  2004-02       Impact factor: 2.490

Review 3.  Heavy chain disease.

Authors:  Thomas E Witzig; Dietlind L Wahner-Roedler
Journal:  Curr Treat Options Oncol       Date:  2002-06

Review 4.  Heavy-Chain Diseases and Myeloma-Associated Fanconi Syndrome: an Update.

Authors:  Roberto Ria; Franco Dammacco; Angelo Vacca
Journal:  Mediterr J Hematol Infect Dis       Date:  2018-01-01       Impact factor: 2.576

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.